logo
Share SHARE
FONT-SIZE Plus   Neg

Abbott Labs To Acquire IDEV Technologies, OptiMedica - Quick Facts

Abbott Laboratories (ABT) announced Monday that it has entered into an agreement to acquire IDEV Technologies, a privately held company focused on developing next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists,for $310 million net of cash and debt.

IDEV Technologies' products include SUPERA Veritas, a self-expanding nitinol stent system with CE Mark in Europe for treating blockages in blood vessels due to peripheral artery disease. Stents are used to prop open a blocked vessel and prevent re-blockage.

IDEV Technologies is headquartered in Webster,Texas. The transaction is expected to close by the end of the year and will not impact Abbott's ongoing full-year 2013 earnings-per-share guidance.

In a separate press release, Abbott announced it has entered into an agreement to purchase OptiMedica Corporation, a privately held Silicon Valley-based ophthalmic device company, for $250 million, net of cash, plus additional payments totaling up to $150 million upon completion of certain development, regulatory or sales milestones.

The company said that the acquisition will enable it to expand its vision care business into the femtosecond laser-assisted cataract surgery market.

The transaction is expected to close by the end of the year and will not impact Abbott's ongoing full-year 2013 earnings-per-share guidance. The transaction is subject to customary closing conditions, including antitrust clearances.

According to the company, OptiMedica's Catalys Precision Laser System is designed to allow surgeons to replace some of the technically demanding manual steps in cataract surgery with a precise, computer-guided, femtosecond laser technology.

The Catalys laser system is indicated for use in patients undergoing cataract surgery for removal of the crystalline lens, with the intended uses: anterior capsulotomy; phacofragmentation and creation of single and multi-plane arc incisions in the cornea.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Everyone knows that the Federal Reserve will raise interest rates next Wednesday at the conclusion of its two-day policy meeting. After all, Fed speakers have been jawboning a rate hike over the past few weeks. With the markets reacting with eerie calm to Donald Trump's win, policy makers have no... GOP strategist Karl Rove has criticized U.S. President-elect Donald Trump's comments on aircraft maker Boeing Co.'s contract for a new Air Force One plane, saying they were inaccurate and de-stabled the stock of a major company. Air Force One is the official air plane for the U.S. President. Elon Musk's space transport company SpaceX has lost a satellite launch order from one of its customers due to the delay in its rocket launch schedule after one of its rockets exploded in September.
comments powered by Disqus
Follow RTT